Crossmark

How COVID-19 pandemic changed our management strategies for amyotrophic lateral sclerosis (ALS) patients: Egyptian study

Published Online: 2021-10-04

Published Print: 2021-12

Authors

Rashed, Hebatallah R. https://orcid.org/0000-0001-6154-806X
License Information

Text and Data Mining valid from 2021-10-04

Version of Record valid from 2021-10-04
More Information

Article History

Received: 26 March 2021

Accepted: 30 May 2021

First Online: 4 October 2021

Ethics approval and consent to participate

: This manuscript was approved from the local Ethical Committee of neurology department, at the international medical center (IMC), on 27/06/2020. Reference number is not applicable. All patients provided written consents by themselves to use their data in research purposes.

: All patients provided informed consents by themselves for publishing their cases.

: The author declares no competing interests.

Document is current